Spyros Papapetropoulos

Insider Reports History

Entity
Individual
Location
C/O Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, Emeryville, CA
Signature
/s/ Spyridon Papapetropoulos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Spyros Papapetropoulos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lipocine Inc. Director Stock Option (Right to Buy) 5.41K $38.1K $7.05 Jun 5, 2024 Direct
Vigil Neuroscience, Inc. Chief Medical Officer Common Stock 4K $15K $3.75 Nov 18, 2022 Direct
BIONOMICS LIMITED/FI Chief Executive Officer, Director Ordinary Shares 6M Jul 1, 2024 Direct
Vigil Neuroscience, Inc. Chief Medical Officer Stock Option Grant (Right to Buy) 150K Nov 18, 2022 Direct
Adamas Pharmaceuticals Inc Director Common Stock 0 $5.16 Nov 24, 2021 Direct
Adamas Pharmaceuticals Inc Director Stock Option (Right to Buy) 0 Nov 24, 2021 Direct

Insider Reports Filed by Spyros Papapetropoulos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BNOX BIONOMICS LIMITED/FI Jul 1, 2024 0 $0 3 Jul 8, 2024 Chief Executive Officer, Director
LPCN Lipocine Inc. Jun 5, 2024 1 $12.4K 4 Jun 7, 2024 Director
LPCN Lipocine Inc. May 10, 2023 1 $7.97K 4 May 12, 2023 Director
LPCN Lipocine Inc. Nov 22, 2022 1 $10.2K 4 Nov 28, 2022 Director
VIGL Vigil Neuroscience, Inc. Nov 18, 2022 3 -$3.63K 4 Nov 22, 2022 Chief Medical Officer
LPCN Lipocine Inc. Jun 8, 2022 1 $20.2K 4 Jun 10, 2022 Director
VIGL Vigil Neuroscience, Inc. May 3, 2022 1 $13.6K 4 May 4, 2022 Chief Medical Officer
LPCN Lipocine Inc. Apr 11, 2022 1 $11.6K 4 Apr 12, 2022 Director
LPCN Lipocine Inc. Apr 11, 2022 0 $0 3 Apr 12, 2022 Director
VIGL Vigil Neuroscience, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Chief Medical Officer
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Chief Medical Officer
ADMS Adamas Pharmaceuticals Inc Nov 24, 2021 3 $0 4 Nov 24, 2021 Director
ADMS Adamas Pharmaceuticals Inc Jun 2, 2021 2 $0 4 Jun 4, 2021 Director